Abstract:Objective: We prospectively compared the detectability of hepatocellular carcinoma (HCC) arising in cirrhotic livers using dynamic gadolinium-enhanced fast low-angle shot (FLASH), ferumoxides-enhanced T2-weighted turbo spin-echo, and ferumoxides-enhanced T2*-weighted FLASH MR imaging. Subjects and methods: Fifty-three patients with HCC (32 men and 21 women) who were 33-86 years old (mean, 63 years old) were enrolled in a prospective MR study to assess hepatic lesions using both gadopentetate dimeglumine and ferumoxides. Dynamic gadolinium-enhanced imaging was obtained before and 30, 60, and 180 sec after rapid bolus injection of gadopentetate dimeglumine (0.1 mmol/kg). Ferumoxides-enhanced T2-weighted turbo spin-echo imaging and ferumoxides-enhanced T2*-weighted FLASH imaging were performed between 30 min and 2 hr after i.v. infusion of ferumoxides (10 micromol/kg). Images were analyzed qualitatively and quantitatively. A receiver operating characteristic curve study was performed to compare the diagnostic value of gadolinium-enhanced imaging with that of ferumoxides-enhanced imaging for the detection of HCC. Results: Quantitative analysis revealed a significantly higher percentage of signal-intensity loss and higher liver-lesion contrast-to-noise ratio on ferumoxides-enhanced T2*-weighted FLASH imaging than on ferumoxides-enhanced T2-weighted turbo spin-echo imaging. The percentage of signal-intensity loss and liver-lesion contrast-to-noise ratio on ferumoxides-enhanced images was significantly higher in patients with mild liver cirrhosis (Child's class A) than in patients with severe liver cirrhosis (Child's class C). Qualitative analysis showed that dynamic gadolinium-enhanced images revealed significantly higher lesion conspicuity than did ferumoxides-enhanced T2-weighted turbo spin-echo images. According to receiver operating characteristic analysis, dynamic gadolinium-enhanced FLASH imaging achieved the highest sensitivity, and ferumoxides-enhanced T2*-weighted FLASH imaging was the second most sensitive. We found that ferumoxides-enhanced turbo spin-echo imaging was the least valuable technique for revealing HCC lesions. Gadolinium-enhanced imaging revealed more HCC lesions than did ferumoxides-enhanced imaging, particularly for lesions smaller than 2 cm in diameter. Conclusion: Ferumoxides-enhanced imaging revealed fewer findings, such as lesion conspicuity of HCCs arising in cirrhotic livers, than did gadolinium-enhanced FLASH imaging.

The comparative study of ferucarbotran enhanced MRI in detecting focal hepatic lesions

Ferucarbotran Versus Gd-DTPA-enhanced MR Imaging in the Detection of Focal Hepatic Lesions.

Detection of small hepatocellular carcinoma: comparison of conventional gadolinium-enhanced MRI with gadolinium-enhanced MRI after the administration of ferucarbotran

To Evaluate the Ability of Feridex-Enhanced MR Imaging to Detect Focal Hepatic Lesions with Two Ways of Methodology

Diagnostic Value of Focal Hepatic Lesions:Comparison of Feridexs-Enhanced MR Imaging with Enhanced Spiral CT by ROC Analysis

Study of Clinical Application of Hepatic-Biliary Specific MR Contrast Agent(gd-Eob-dtpa) in the Diagnosis of Focal Hepatic Lesions

Value of Feridex-enhanced MRI for Detection of Focal Hepatic Lesions and Analysis of Its Relevant Pathological Basis

Comparative the Clinical Value of Contrast-Enhanced Ultrasonography, Enhancement CT and MRI for Diagnosing of Liver Lesions.

Evaluation of Feridex-enhanced MRI in the Diagnosis of Focal Hepatic Lesions

Feridex-enhanced MRI for the Detection of Focal Hepatic Lesions: A Preliminary Report

Validation study of perfusion parameter in hypervascular hepatocellular carcinoma and focal nodular hyperplasia using dynamic susceptibility magnetic resonance imaging with super-paramagnetic iron oxide: comparison with single level dynamic CT arteriography

Characterization of focal liver lesions: comparison of MRI and MSCT

Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging

Application of 3D FAME Dynamic Contrast -Enhanced MRI in the Diagnosis of Focal Hepatic Lesions

A Compared Study on Gd+-EOB-DTPA and Gd+-DTPA-enhanced MRI in Detection of Hepatocellular Carcinoma

Utility of combined gadoxetic acid and ferumoxytol-enhanced liver MRI for preoperative detection of colorectal cancer liver metastases: a pilot study

Assessment of Liver Fibrosis Using Pharmacokinetic Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging

Comparison of Enhancement Features of Peripheral Intrahepatic Cholangiocarcinoma on Contrastenhanced Ultrasound and Dynamic Enhanced MRI

Gd+-EOB-DTPA-enhanced MRI evaluation of colorectal liver metastases and chemotherapy-induced fatty liver

Focal Liver Lesions: Real-time 3-Dimensional Contrast-Enhanced Ultrasonography Compared With 2-Dimensional Contrast-Enhanced Ultrasonography and Magnetic Resonance Imaging.